Revacept in Symptomatic Carotid Stenosis

NCT01645306 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Carotid Stenosis
Atherosclerosis
Stroke
Transient-ischaemic Attack
TIA
Amaurosis Fugax

Interventions

DRUG: Revacept
DRUG: Placebo

Sponsor

AdvanceCor GmbH